Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability
To access this article, please choose from the options below
PII: S0021-9150(10)00436-3
doi:10.1016/j.atherosclerosis.2010.06.018
© 2010 Elsevier Ireland Ltd. All rights reserved.
